DC-U4106 is a USP8-targeted inhibitor (Kd: 4.7 µM, IC50: 1.2 µM). DC-U4106 can use the ubiquitination pathway to promote the degradation of Eralpha. DC-U4106 inhibits the growth of tumor cells with low toxicity and can be used to study breast cancer.
Molecular Weight:
525.56
CAS Number:
[2410534-62-0]
Formula:
C29H27N5O5
Target:
Others|||DUB|||Apoptosis
T63685
* VAT and and shipping costs not included. Errors and price changes excepted
